Relugolix and Enzalutamide: Clinical Trials

1 trial of Relugolix and Enzalutamide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow Relugolix and Enzalutamide: new trials by email Literature Review of Relugolix and Enzalutamide trials Research Report on Relugolix and Enzalutamide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Relugolix + Enzalutamide Study in High-Risk Prostate Cancer
Relugolix and Enzalutamide - Androgen Deprivation Therapy, Locally Advanced Prostate Cancer
Phase 1RecruitingUniversity of Oklahoma462024-12-262026-03-05

Conditions studied

Neoplasm, Residual (1)  ·  Pathologic Complete Response (1)

Sponsors

University of Oklahoma (1)

Countries

United States (1)

Results publications

PMID 42031503